The Europe Spine Bone Stimulators Market would witness market growth of 4.0% CAGR during the forecast period (2022-2028).
The consumption of spinal bone stimulators is likely to rise due to a growth in the geriatric population, an increase in the frequency of spinal abnormalities, and an increase in the need for suitable healthcare facilities. To meet the needs of the rising patient pool, emerging countries must also be focusing on cost and scalability.
Stability is achieved mostly by implanting screws and stabilizing rods into the spinal bones. This helps to stabilize the bone, allowing new bone to grow across the formerly movable joints (fusion). A bone graft is used to support bone or bone proteins that would lead to the union. Although fusion is the primary goal, doctors devote all efforts to bridge the distance between two spinal segments with bone.
There are varied growth chances for regional market players due to favorable health insurance, growing demands for 3D printed hospital devices in Germany and the United Kingdom, and a continuous step ahead into less invasive surgeries. Furthermore, increased government financing for biologics and orthopedic surgery implants is likely to move the European industry forward.
In France, almost a million people suffer from spinal cord injuries each year due to technological advancements in spinal surgery equipment. A large number of them may suffer from tetraplegia or paraplegia as a result of spinal injuries, leaving them crippled for life. These rates are expected to grow even more as lifestyles and food consumption habits change in the country.
According to the publication The Heavy Burden of Obesity by the Organization for Economic Cooperation and Development (OECD), one out of every four persons in Germany was obese in 2019. As a result, overweight persons in Germany live an average of two years fewer. These figures are expected to climb much more as people's lifestyles and food consumption habits change in developed countries. Obesity is expected to increase the number of persons who have spinal problems, as well as those who have degenerative spinal conditions. The adoption of the spine bone stimulator for the quick recovery enhances the growth of the market.
The Germany market dominated the Europe Spine Bone Stimulators Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $42.4 million by 2028. The UK market is estimated to grow at a CAGR of 3.1% during (2022 - 2028). Additionally, The France market would display a CAGR of 4.7% during (2022 - 2028).
Based on Device Type, the market is segmented into Non-Invasive and Invasive. Based on End User, the market is segmented into Hospitals, Specialty Clinics, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
Free Valuable Insights: The Global Spine Bone Stimulators Market Size will Hit $626.2 Million by 2028, at a CAGR of 4.1%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include DJO Global, Inc. (Enovis), Zimmer Biomet, Orthofix Medical Inc., Elizur Corporation, Ossatec Benelux BV, IGEA S.p.A., ManaMed Inc., Theragen, Inc., Intelligent Implants, and Orchid Medical, Inc
By Device Type
By End User
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
